Folate receptor near-infrared imaging involves the use of OTL38 (On Target Laboratories, West Lafayette, Indiana, USA), a folate analog conjugated to a cyanine dye, as a biomarker for tumor tissues that overexpress folate receptor alpha (Cho et al., 2018, 2020). The gene discussed is FOLR1; the disease is neoplasm.